Kineta (KA)

Kineta (KA) Stock Price & Analysis


KA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.79 - $9.00
Previous Close$3.04
Average Volume (3M)25.32K
Market Cap
Enterprise Value$21.83M
Total Cash (Recent Filing)$9.20M
Total Debt (Recent Filing)$2.06M
Price to Earnings (P/E)-0.1
Aug 10, 2023
EPS EstimateN/A
1.43 (47.01%)
Share Statistics
EPS (TTM)-20.85
Shares Outstanding9,761,339
10 Day Avg. Volume13,079
30 Day Avg. Volume25,316
Standard Deviation0.34
Financial Highlights & Ratios
Price to Book (P/B)-162.93
Price to Sales (P/S)15.19
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue18.02
Enterprise Value/Gross Profit11.18
Enterprise Value/Ebitda-0.60
Price Target Upside163.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Kineta’s price range in the past 12 months?
Kineta lowest stock price was $1.79 and its highest was $9.00 in the past 12 months.
    What is Kineta’s market cap?
    Currently, no data Available
    When is Kineta’s upcoming earnings report date?
    Kineta’s upcoming earnings report date is Aug 10, 2023 which is in 72 days.
      How were Kineta’s earnings last quarter?
      Currently, no data Available
      Is Kineta overvalued?
      According to Wall Street analysts Kineta’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Kineta pay dividends?
        Kineta pays a Notavailable dividend of $1.43 which represents an annual dividend yield of N/A. See more information on Kineta dividends here
          What is Kineta’s EPS estimate?
          Kineta’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Kineta have?
          Kineta has 9,490,302 shares outstanding.
            What happened to Kineta’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Kineta?
            Among the largest hedge funds holding Kineta’s share is Harbourvest Partners Llc. It holds Kineta’s shares valued at N/A.


              Kineta Stock Smart Score

              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description


              Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.


              Top 5 ETFs holding KA

              Currently, no data available
              Please return soon. This page is being updated.
              Up to five ETFs with an Outperform Smart Score that hold KA. The ETFs are listed according to market value of KA within the ETF


              Forecast EPS vs Actual EPS

              Currently, no data available
              Please return soon. This page is being updated.

              Similar Stocks
              Price & Change
              GeoVax Labs
              Aprea Therapeutics
              Enzon Pharmaceuticals
              Dominari Holdings

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis